Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease.
OBJECTIVE
To identify the gene causing a severe form of progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease and to characterize clinical features in a large American family.


METHODS
We characterized an American family who had an unusual retinal dystrophy with clinical features of Stargardt disease and severe progressive cone-rod dystrophy. Family members underwent complete ocular examinations with evaluation of visual acuity, visual fields, fundus examination, fluorescein angiography, and electroretinography. Genome-wide linkage analysis of the family was performed using 408 microsatellite markers spanning the entire human genome. Direct DNA sequence analysis was used for mutational analysis of the ABCA4 gene in all exons and exon-intron boundary regions and for testing cosegregation of the mutations with the disease in the family. DNA sequence analysis was used to determine the presence of the mutations in 200 unrelated controls.


RESULTS
The proband presented with a clinical phenotype that was initially compatible with Stargardt disease, only to progress to a severe cone-rod dystrophy over the course of a few years. The disease-causing gene in the family was linked to the ABCA4 locus on chromosomal 1p22. One novel mutation, c.655A>T, was identified in exon 6 and another novel splicing mutation, c.5312+3A>T, was identified in intron 37 of ABCA4. The mutations were not present in 200 controls. The two affected sisters in this pedigree were compound heterozygotes for the mutations. Unaffected family members either did not carry either or had only one of the two mutations.


CONCLUSIONS
We have identified two novel ABCA4 mutations, c.655A>T and c.5312+3A>T. When present as a compound heterozygous state, the mutations cause a phenotype of retinal dystrophy that initially manifests as Stargardt disease and slowly progresses to a severe cone-rod dystrophy. These results expand the wide range of clinical manifestations of ABCA4 mutations.
Xi
Quansheng
Q
Department of Molecular Cardiology, Center for Cardiovascular Genetics, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH, USA.
Li
Lin
L
Traboulsi
Elias I
EI
Wang
Qing Kenneth
QK
D018528:ATP-Binding Cassette Transporters / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D004252:DNA Mutational Analysis; D004596:Electroretinography; D005260:Female; D005451:Fluorescein Angiography; D005808:Genes, Recessive; D055106:Genome-Wide Association Study; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D009759:Nystagmus, Pathologic; D010375:Pedigree; D020419:Photoreceptor Cells, Vertebrate / Q000473:pathology; D017354:Point Mutation; D012174:Retinitis Pigmentosa / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D015354:Vision, Low
C056475:ABCA4 protein, human; D018528:ATP-Binding Cassette Transporters